IMPL - Impel NeuroPharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

99.39M

Cash

15.16M

Avg Qtr Burn

-21.31M

Short % of Float

10.53%

Insider Ownership

1.08%

Institutional Own.

74.61%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TRUDHESA (Dihydroergotamine Mesylate) Details Migraines	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INP107 (Levodopa/Carbidopa) Details Morning OFF Episodes in Parkinson’s	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INP105 (Olanzapine) Details Agitation	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.